Spotlight

M&A and Distressed Transactions

M&A

An upsurge in healthcare M&A is on its way in America as the pandemic impels providers who had been contemplating a transaction to take action for offensive growth or defensive protection.

Some have been exploring buying opportunities to expand and accelerate growth. Others have considered a strategic partnership to secure economic stability and capital for a dynamic, thriving future. Distressed organizations, now further in jeopardy, are looking to sell in hopes of preserving a level of healthcare in the community.

All healthcare providers hold a unique position in their communities – at the intersection of health, business and politics. Few things are as important for them than a transaction or major partnership.

That’s why realizing the full benefits of any transaction requires careful articulation of “the why,” clear communication through deal close and deep understanding of how to navigate political and emotional stakeholder relations to secure buy-in.

We can help.

Our firm is the national leader in healthcare transaction communications and has unparalleled experience working through transactions of all shapes undertaken to preserve healthcare in communities across America.

We work alongside you throughout the process, whether preparing to find a partner, readying to buy or divesting.

Our expertise covers: Buy Side, Sell Side, Joint Ventures, Bankruptcy, Restructuring.

$60 billion in M&A

For more on our experience with distressed transactions:

For more on our M&A services in this new era of healthcare:

Our deep industry knowledge and sharp political thinking leads to transactions that:

ADVANCE

your mission

PROTECT

your reputation

PREPARE

for integration

CLOSE

on time

Our clients cover the spectrum of healthcare providers:

Not-for-profit health systems

Invester-owned health systems

Academic medical centers

Large physician groups

Behavioral health companies

Post-acute companies

Ambulatory healthcare companies

Other provider organizations

Our Latest Thinking on M&A